BACKGROUND Arthroscopic debridement is a mature treatment for knee osteoarthritis(KOA).Due to the differences in the research subjects,methods,and efficacy evaluation indexes,there are great differences in the surgica...BACKGROUND Arthroscopic debridement is a mature treatment for knee osteoarthritis(KOA).Due to the differences in the research subjects,methods,and efficacy evaluation indexes,there are great differences in the surgical efficacy reported in the literature.AIM To compare the medium-term efficacy of arthroscopic debridement and conservative treatment for KOA of Kellgren-Lawrence grades I-III.METHODS Patients with KOA of Kellgren-Lawrence grades I-III who were admitted to the orthopedic clinic of our hospital from July 2018 to December 2018 and agreed to undergo arthroscopic surgery were included in an arthroscopic debridement group,and those who refused surgical treatment were included in a conservative treatment group.Gender,age,body mass index(BMI),side of KOA,American hospital for special surgery knee score(HSS score)before treatment,visual analogue scale(VAS)score during walking and rest before treatment,conservative treatment content,and surgical procedure were recorded.Outpatient visits were conducted at the 1st,3rd,6th,12th,and 24th mo after treatment in the two groups.The changes of HSS score and VAS score in each group before and after treatment were statistically analyzed,and the differences of HSS score and VAS score in different treatment stages between the two groups were also compared.RESULTS In the conservative treatment group,there were 80 patients with complete followup data,including 20 males and 60 females,aged 58.75±14.66 years old.And in the knee arthroscopic debridement group,there were 98 patients with complete follow-up data,including 24 males and 74 females,aged 59.27±14.48 years old.There was no statistically significant difference in the general data(gender,age,BMI,side of KOA,Kellgren-Lawrence grade distribution,HSS score,and VAS score)between the two groups before treatment.The HSS scores of the conservative treatment group at the 1st,3rd,6th,12th,and 24th mo after treatment were significantly higher than that before treatment(P<0.05).There was no statistical difference in HSS score of the conservative treatment group among the 1st,3rd,6th,12th,and 24th mo(P>0.05).The HSS score of the knee arthroscopic debridement group at the 1st mo after surgery was significantly higher than that before surgery(P<0.05).HSS scores of the knee arthroscopic debridement group at the 3rd,6th,12th,and 24th mo were significantly higher than those before surgery and at the 1st mo after surgery(P<0.05).There were no statistically significant differences in HSS scores at the 3rd,6th,12th,and 24th mo after surgery(P>0.05).HSS scores at the 3rd,6th,12th,and 24th mo were significantly higher in the arthroscopic debridement group than in the conservative treatment group(P<0.05).There was no statistical difference in HSS scores between the two groups before treatment and at the 1st mo of follow-up(P>0.05).VAS scores during walking and rest were significantly decreased in both groups,and the VAS score during rest was significantly lower in the arthroscopic debridement group than in the conservative treatment group,but there was no significant difference in the VAS score during walking between the two groups after treatment.CONCLUSION Compared with conservative treatment,arthroscopic debridement can significantly improve the knee resting pain and knee functional status of patients with KOA of Kellgren-Lawrence grades I-III within 2 years after treatment.展开更多
Method of selecting points in foot-hand same-name meridians was used to treat 24 cases of Osteoarthritis of knee joint, and the therapeutic results showed 15 cases were cured, 4 cases got significant effect and 4 case...Method of selecting points in foot-hand same-name meridians was used to treat 24 cases of Osteoarthritis of knee joint, and the therapeutic results showed 15 cases were cured, 4 cases got significant effect and 4 cases got improvement. Key Words Acupuncture Therapy - Knee Joint - Osteoarthritis - Point Combination Author: Han Cai-yun (1970-), female, Mongolia nation, attending physicianTranslator: Wu Xue-fei展开更多
Background：Knee osteoarthritis （KOA） is a chronic joint disease that manifests as knee pain as well as different degrees of lower limb swelling,stiffness,and movement disorders.The therapeutic goal is to alleviate ...Background：Knee osteoarthritis （KOA） is a chronic joint disease that manifests as knee pain as well as different degrees of lower limb swelling,stiffness,and movement disorders.The therapeutic goal is to alleviate or eliminate pain,correct deformities,improve or restore joint functions,and improve the quality of life.This study aimed to evaluate the efficacy and safety of Zhuanggu joint capsules combined with celecoxib and the benefit of treatment with Zhuanggu alone for KOA.Methods：This multi-center,randomized,double-blind,double-dummy,parallel controlled trial,started from December 2011 to May 2014,was carried out in 6 cities,including Beijing,Shanghai,Chongqing,Changchun,Chengdu,and Nanjing.A total of 432 patients with KOA were divided into three groups （144 cases in each group）.The groups were treated,respectively,with Zhuanggu joint capsules combined with celecoxib capsule simulants,Zhuanggu joint capsules combined with celecoxib capsules,and celecoxib capsules combined with Zhuanggu joint capsule simulants for 4 weeks consecutively.The improvement of Western Ontario and McMaster Universities Osteoarthritis （WOMAC） index and the decreased rates in each dimension of WOMAC were evaluated before and after the treatment.Intergroup and intragroup comparisons of quantitative indices were performed.Statistically significant differences were evaluated with pairwise comparisons using Chi-square test （or Fisher＆#39;s exact test） and an inspection level ofα =0.0167.Results：Four weeks after treatment,the total efficacies of Zhuanggu group,combination group,and celecoxib group were 65%,80%,and 64%,respectively,with statistically significant differences among the three groups （P =0.005）.Intergroup pairwise comparisons showed that the total efficacy of the combination group was significantly higher than that of the Zhuanggu （P =0.005） and celecoxib （P =0.003）groups.The difference between the latter two groups was not statistically significant （P 〉 0.0167）.Four weeks after discontinuation,the efficacies of the three groups were 78%,95%,and 65%,respectively,with statistically significant differences （P 〈 0.0001）.Intergroup pairwise comparisons revealed that the efficacy of the combination group was significantly better than that of the Zhuanggu and the celecoxib groups （P 〈 0.0001）.The difference between the latter two groups was not statistically significant （P 〉 0.0167）.The incidences of adverse events in Zhuanggu group,combination group,and celecoxib group were 8.5%,8.5%,and 11.1%,respectively,with insignificant differences （P 〉 0.05）.Conclusions：Zhuanggu joint capsules alone or combined with celecoxib showed clinical efficacy in the treatment of KOA.The safety of Zhuanggu joint capsules alone or combined with celecoxib was acceptable.展开更多
目的:观察脉冲射频术治疗膝关节骨关节炎的临床疗效。方法:前瞻性收集2015年1月至2015年6月解放军总医院第一附属医院收治的符合纳入及排除标准的膝关节骨关节炎患者96例,随机分为试验组(予以脉冲射频术治疗,n=48)和对照组(予以口服塞...目的:观察脉冲射频术治疗膝关节骨关节炎的临床疗效。方法:前瞻性收集2015年1月至2015年6月解放军总医院第一附属医院收治的符合纳入及排除标准的膝关节骨关节炎患者96例,随机分为试验组(予以脉冲射频术治疗,n=48)和对照组(予以口服塞来昔布胶囊6周治疗,n=48)。分别于治疗前、治疗后1个月和6个月随访并比较两组患者在视觉模拟评分(visual analogue scale,VAS)和西安大略和麦克马斯特大学骨关节炎指数(western Ontario and Mc Master Universities Osteoarthritis Index,WOMAC)方面的差异。结果:最终试验组患者45例(93.8%),对照组患者47例(97.9%)完成随访。两组患者治疗前VAS和WOMAC均无显著性差异。治疗后,试验组VAS和WOMAC均显著低于治疗前,差异有统计学意义(P<0.001)。组间比较疼痛方面,试验组治疗后1个月和6个月VAS均低于对照组,差异有统计学意义(P<0.05);膝关节功能方面,试验组治疗后1个月和6个月WOMAC也均低于对照组,差异有统计学意义(P<0.05)。结论:脉冲射频术治疗膝关节骨关节炎效果优于口服塞来昔布,可以显著减轻患者疼痛,改善膝关节功能。展开更多
目的：观察黄芩清热除痹胶囊口服联合芙蓉膏外敷治疗膝骨关节炎湿热痹阻型的临床疗效。方法60例膝骨关节炎患者，年龄40～70岁，中医辨证属湿热痹阻证者，随机分为治疗组30例与对照组30例，治疗组用黄芩清热除痹胶囊口服配合芙蓉膏外敷...目的：观察黄芩清热除痹胶囊口服联合芙蓉膏外敷治疗膝骨关节炎湿热痹阻型的临床疗效。方法60例膝骨关节炎患者，年龄40～70岁，中医辨证属湿热痹阻证者，随机分为治疗组30例与对照组30例，治疗组用黄芩清热除痹胶囊口服配合芙蓉膏外敷，疗程为2周，对照组给予氨基葡萄糖、美洛昔康口服治疗。结果治疗组总有效率96．7％，对照组总有效率76．7％，治疗组总有效率优于对照组，差异具有统计学意义（P ＜0．05）；两组治疗后均能显著降低患者中医证候总积分、关节疼痛 VAS 评分、WOMAC 指数、血沉（ESR），C －反应蛋白（CRP）水平（P ＜0．05或 P ＜0．01），两组治疗后比较，治疗组 VAS 评分、WOMAC 指数、ESR、CRP 下降的更明显（P ＜0．05或 P ＜0．01）；治疗组在上调超氧化物歧化酶（SOD）方面优于对照组（P＜0．05）；两组治疗后谷丙转氨酶（ALT）、谷草转氨酶（AST）、肌酐（Cre）、血常规均在正常范围。结论黄芩清热除痹胶囊口服联合芙蓉膏外敷能有效改善膝骨关节炎急性期症状，减轻患者疼痛 VAS 评分、WOMAC 指数、降低 ESR、CRP，起效迅速，且安全性良好，未见明显毒副作用。展开更多
基金Shanghai Jing'an District Health Research Project,China,No.2018MS09.
文摘BACKGROUND Arthroscopic debridement is a mature treatment for knee osteoarthritis(KOA).Due to the differences in the research subjects,methods,and efficacy evaluation indexes,there are great differences in the surgical efficacy reported in the literature.AIM To compare the medium-term efficacy of arthroscopic debridement and conservative treatment for KOA of Kellgren-Lawrence grades I-III.METHODS Patients with KOA of Kellgren-Lawrence grades I-III who were admitted to the orthopedic clinic of our hospital from July 2018 to December 2018 and agreed to undergo arthroscopic surgery were included in an arthroscopic debridement group,and those who refused surgical treatment were included in a conservative treatment group.Gender,age,body mass index(BMI),side of KOA,American hospital for special surgery knee score(HSS score)before treatment,visual analogue scale(VAS)score during walking and rest before treatment,conservative treatment content,and surgical procedure were recorded.Outpatient visits were conducted at the 1st,3rd,6th,12th,and 24th mo after treatment in the two groups.The changes of HSS score and VAS score in each group before and after treatment were statistically analyzed,and the differences of HSS score and VAS score in different treatment stages between the two groups were also compared.RESULTS In the conservative treatment group,there were 80 patients with complete followup data,including 20 males and 60 females,aged 58.75±14.66 years old.And in the knee arthroscopic debridement group,there were 98 patients with complete follow-up data,including 24 males and 74 females,aged 59.27±14.48 years old.There was no statistically significant difference in the general data(gender,age,BMI,side of KOA,Kellgren-Lawrence grade distribution,HSS score,and VAS score)between the two groups before treatment.The HSS scores of the conservative treatment group at the 1st,3rd,6th,12th,and 24th mo after treatment were significantly higher than that before treatment(P<0.05).There was no statistical difference in HSS score of the conservative treatment group among the 1st,3rd,6th,12th,and 24th mo(P>0.05).The HSS score of the knee arthroscopic debridement group at the 1st mo after surgery was significantly higher than that before surgery(P<0.05).HSS scores of the knee arthroscopic debridement group at the 3rd,6th,12th,and 24th mo were significantly higher than those before surgery and at the 1st mo after surgery(P<0.05).There were no statistically significant differences in HSS scores at the 3rd,6th,12th,and 24th mo after surgery(P>0.05).HSS scores at the 3rd,6th,12th,and 24th mo were significantly higher in the arthroscopic debridement group than in the conservative treatment group(P<0.05).There was no statistical difference in HSS scores between the two groups before treatment and at the 1st mo of follow-up(P>0.05).VAS scores during walking and rest were significantly decreased in both groups,and the VAS score during rest was significantly lower in the arthroscopic debridement group than in the conservative treatment group,but there was no significant difference in the VAS score during walking between the two groups after treatment.CONCLUSION Compared with conservative treatment,arthroscopic debridement can significantly improve the knee resting pain and knee functional status of patients with KOA of Kellgren-Lawrence grades I-III within 2 years after treatment.
文摘Method of selecting points in foot-hand same-name meridians was used to treat 24 cases of Osteoarthritis of knee joint, and the therapeutic results showed 15 cases were cured, 4 cases got significant effect and 4 cases got improvement. Key Words Acupuncture Therapy - Knee Joint - Osteoarthritis - Point Combination Author: Han Cai-yun (1970-), female, Mongolia nation, attending physicianTranslator: Wu Xue-fei
文摘Background：Knee osteoarthritis （KOA） is a chronic joint disease that manifests as knee pain as well as different degrees of lower limb swelling,stiffness,and movement disorders.The therapeutic goal is to alleviate or eliminate pain,correct deformities,improve or restore joint functions,and improve the quality of life.This study aimed to evaluate the efficacy and safety of Zhuanggu joint capsules combined with celecoxib and the benefit of treatment with Zhuanggu alone for KOA.Methods：This multi-center,randomized,double-blind,double-dummy,parallel controlled trial,started from December 2011 to May 2014,was carried out in 6 cities,including Beijing,Shanghai,Chongqing,Changchun,Chengdu,and Nanjing.A total of 432 patients with KOA were divided into three groups （144 cases in each group）.The groups were treated,respectively,with Zhuanggu joint capsules combined with celecoxib capsule simulants,Zhuanggu joint capsules combined with celecoxib capsules,and celecoxib capsules combined with Zhuanggu joint capsule simulants for 4 weeks consecutively.The improvement of Western Ontario and McMaster Universities Osteoarthritis （WOMAC） index and the decreased rates in each dimension of WOMAC were evaluated before and after the treatment.Intergroup and intragroup comparisons of quantitative indices were performed.Statistically significant differences were evaluated with pairwise comparisons using Chi-square test （or Fisher＆#39;s exact test） and an inspection level ofα =0.0167.Results：Four weeks after treatment,the total efficacies of Zhuanggu group,combination group,and celecoxib group were 65%,80%,and 64%,respectively,with statistically significant differences among the three groups （P =0.005）.Intergroup pairwise comparisons showed that the total efficacy of the combination group was significantly higher than that of the Zhuanggu （P =0.005） and celecoxib （P =0.003）groups.The difference between the latter two groups was not statistically significant （P 〉 0.0167）.Four weeks after discontinuation,the efficacies of the three groups were 78%,95%,and 65%,respectively,with statistically significant differences （P 〈 0.0001）.Intergroup pairwise comparisons revealed that the efficacy of the combination group was significantly better than that of the Zhuanggu and the celecoxib groups （P 〈 0.0001）.The difference between the latter two groups was not statistically significant （P 〉 0.0167）.The incidences of adverse events in Zhuanggu group,combination group,and celecoxib group were 8.5%,8.5%,and 11.1%,respectively,with insignificant differences （P 〉 0.05）.Conclusions：Zhuanggu joint capsules alone or combined with celecoxib showed clinical efficacy in the treatment of KOA.The safety of Zhuanggu joint capsules alone or combined with celecoxib was acceptable.
文摘目的:观察脉冲射频术治疗膝关节骨关节炎的临床疗效。方法:前瞻性收集2015年1月至2015年6月解放军总医院第一附属医院收治的符合纳入及排除标准的膝关节骨关节炎患者96例,随机分为试验组(予以脉冲射频术治疗,n=48)和对照组(予以口服塞来昔布胶囊6周治疗,n=48)。分别于治疗前、治疗后1个月和6个月随访并比较两组患者在视觉模拟评分(visual analogue scale,VAS)和西安大略和麦克马斯特大学骨关节炎指数(western Ontario and Mc Master Universities Osteoarthritis Index,WOMAC)方面的差异。结果:最终试验组患者45例(93.8%),对照组患者47例(97.9%)完成随访。两组患者治疗前VAS和WOMAC均无显著性差异。治疗后,试验组VAS和WOMAC均显著低于治疗前,差异有统计学意义(P<0.001)。组间比较疼痛方面,试验组治疗后1个月和6个月VAS均低于对照组,差异有统计学意义(P<0.05);膝关节功能方面,试验组治疗后1个月和6个月WOMAC也均低于对照组,差异有统计学意义(P<0.05)。结论:脉冲射频术治疗膝关节骨关节炎效果优于口服塞来昔布,可以显著减轻患者疼痛,改善膝关节功能。
文摘目的：观察黄芩清热除痹胶囊口服联合芙蓉膏外敷治疗膝骨关节炎湿热痹阻型的临床疗效。方法60例膝骨关节炎患者，年龄40～70岁，中医辨证属湿热痹阻证者，随机分为治疗组30例与对照组30例，治疗组用黄芩清热除痹胶囊口服配合芙蓉膏外敷，疗程为2周，对照组给予氨基葡萄糖、美洛昔康口服治疗。结果治疗组总有效率96．7％，对照组总有效率76．7％，治疗组总有效率优于对照组，差异具有统计学意义（P ＜0．05）；两组治疗后均能显著降低患者中医证候总积分、关节疼痛 VAS 评分、WOMAC 指数、血沉（ESR），C －反应蛋白（CRP）水平（P ＜0．05或 P ＜0．01），两组治疗后比较，治疗组 VAS 评分、WOMAC 指数、ESR、CRP 下降的更明显（P ＜0．05或 P ＜0．01）；治疗组在上调超氧化物歧化酶（SOD）方面优于对照组（P＜0．05）；两组治疗后谷丙转氨酶（ALT）、谷草转氨酶（AST）、肌酐（Cre）、血常规均在正常范围。结论黄芩清热除痹胶囊口服联合芙蓉膏外敷能有效改善膝骨关节炎急性期症状，减轻患者疼痛 VAS 评分、WOMAC 指数、降低 ESR、CRP，起效迅速，且安全性良好，未见明显毒副作用。
